A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance

Molecular Cell

Volumn 2, Issue 5, 1998, Pages 559-569

  Brüning, Jens C ^a,c   Michael, M Dodson ^a   Winnay, Jonathon N ^a   Hayashi, Tatsuya ^a   Hörsch, Dieter ^a,d   Accili, Domenico ^b   Goodyear, Laurie J ^a   Kahn, C Ronald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CRE RECOMBINASE; CREATINE KINASE; GLUCOSE; INSULIN; INSULIN RECEPTOR; INTEGRASE; ISOENZYME; LIPID; PHOSPHOTYROSINE; VIRUS PROTEIN;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; CELL CULTURE; DRUG EFFECT; FEMALE; GENETICS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; LIVER; MALE; METABOLISM; MOUSE; MOUSE MUTANT; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSGENIC MOUSE;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CELLS, CULTURED; CHOLESTEROL; CREATINE KINASE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; INTEGRASES; ISOENZYMES; LIPIDS; LIVER; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUSCLE, SKELETAL; PHOSPHOTYROSINE; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; VIRAL PROTEINS;

EID: 0032214652     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(00)80155-0     Document Type: Article

References (35)

1. Accili, D., Drago, J., Lee, E.J., Johnson, M.D., Cool, M.H., Salvatore, P., Asico, L.D., Jose, P.A., Taylor, S.I., and Westphal, H.D. (1996). Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet. 12, 106-109.
2. Araki, E., Lipes, M.A., Patti, M.E., Brüning, J.C., Haag, B.L., III, Johnson, R.S., and Kahn, C.R. (1994). Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature 372, 186-190.
3. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seldman, J.G., Smith, J.A., and Struhl, K. (1992). Current protocol in molecular biology (New York: Wiley Interscience).
4. Bar, R.S., Gorden, P., Roth, J., Kahn, C.R., and De Meyts, P. (1976). Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding and dieting. J. Clin. Invest. 58, 1123-1135.
5. Baron, A.D. (1994). Hemodynamic actions of insulin. Am. J. Physiol. 267, E187-E202.
6. Brüning, J.C., Winnay, J., Bonner-Weir, S., Taylor, S.I., Accili, D., and Kahn, C.R. (1997). Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88, 561-572.
7. Caro, J.F., Sinha, M.K., Raju, S.M., Ittoop, O., Pories, W.J., Flickinger, E.G., Meelheim, D., and Dohm, G.L. (1987). Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin-dependent diabetes. J. Clin. Invest. 79, 1330-1337.
8. Chang, P.Y., Benecke, H., Le Marchand-Brustel, Y., Lawitts, J.A., and Moller, D.E. (1994). Expression of a dominant-negative mutant human insulin receptor in the muscle of transgenic mice. J. Biol. Chem. 269, 16034-16040.
9. DeFronzo, R.A. (1997). Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. 5, 177-269.
10. Etgen, G.J., Jr., Fryburg, D.A., and Gibbs, E.M. (1997). Nitric oxide stimulates skeletal muscle glucose transport through a calcium/ contraction-and phosphatidylinositol-3-kinase-independent pathway. Diabetes 46, 1915-1919.
11. Gu, H., Marth, J.D., Orban, P.C., Mossmann, H., and Rajewsky, K. (1994). Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265, 103-106.
12. Johnson, J.E., Wold, B.J., and Hauschka, S.D. (1989). Muscle creatine kinase sequence elements regulating skeletal and cardiac muscle expression in transgenic mice. Mol. Cell Biol. 9, 3393-3399.
13. Joshi, R.L., Lamothe, B., Cordonnier, N., Mesbah, K., Monthioux, E., Jami, J., and Bucchini, C. (1996). Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J. 15, 1542-1547.
14. Kahn, C.R. (1994). Insulin action, diabetogenes, and the cause of type II diabetes (Banting lecture). Diabetes 43, 1066-1084.
15. Kahn, C.R. (1997). Insulin receptors and insulin signaling in normal and disease states. In International Textbook of Diabetes Mellitus. K.G.M.M. Alberti, P. Zimmet, R.A. DeFronzo, and H. Keen, eds. (Chichester, UK: John Wiley and Sons, Ltd.), pp. 437-467.
16. Kahn, C.R., Neville, D.M., Jr., and Roth, J. (1973). Insulin receptor interaction in the obese hyperglycemic mouse. A model of insulin resistance. J. Biol. Chem. 248, 244-250.
17. Katz, E.B., Stenbit, A.E., Hatton, K., DePinho, R.A., and Charron, M.J. (1995). Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377, 151-155.
18. Klip, A., Ramlal, T., Young, D.A., and Holloszy, J.O. (1987). Insulin-induced translocation of glucose transporters in rat hindlimb muscles. Growth Regul. 224, 224-230.
19. Kolterman, O.G., Gray, R.S., Griffin, J., Burstein, P., Insel, J., Scarlett, J.A., and Olefsky, J.M. (1981). Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J. Clin. Invest. 68, 957-969.
20. Lillioja, S., Mott, D.M., Spraul, M., Ferraro, R., Foley, J.E., Ravussin, E., Knowler, W.C., Bennett, P.H., and Bogardus, C. (1993). Insulin resistance and insulin secretory dysfunction as precursors of noninsulin-dependent diabetes mellitus: prospective studies of Pima Indians. N. Engl. J. Med. 329, 1988-1992.
21. Martin, B.C., Warram, J.H., Krolewski, A.S., Bergman, R.N., Soeldner, J.S., and Kahn, C.R. (1992). Role of glucose and insulin resistance in development of type II diabetes mellitus: results of a 25-year follow-up study. Lancet 340, 925-929.
22. Moller, D.E., Chang, P.Y., Yaspelkis, B.B., III, Flier, J.S., Wallberg-Henriksson, H., and Ivy, J.L. (1996). Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia. Endocrinology 137, 2397-2405.
23. Papaioannou, V., and Johnson, R. (1993). Production of chimeras and genetically defined offspring from targeted ES cells. In Gene Targeting: A Practical Approach, A.L. Joyner, ed. (Oxford: Oxford University Press), pp. 107-146.
24. Prince, M.J., Tsai, P., and Olefsky, J.M. (1981). Insulin binding, internalization and insulin receptor regulation in fibroblasts from type II (noninsulin-dependent) diabetic subjects. Diabetes 30, 596-600.
25. Reaven, G.M. (1987). Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism and atherosclerosis. Metabolism 36, 1-8.
26. Stenbit, A.E., Burcelin, R., Katz, E.B., Tsao, T.S., Gautier, N., Charron, M.J., and Le Marchand-Brustel, Y. (1996). Diverse effects of Glut 4 ablation on glucose uptake and glycogen synthesis in red and white skeletal muscle. J. Clin. Invest. 98, 629-634.
27. Stenbit, A.E., Tsao, T.S., Li, J., Burcelin, R., Geenen, D.L., Factor, S.M., Houseknecht, K.L., Katz, E.B., and Charron, M.J. (1997). GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat. Med. 3, 1096-1101.
28. Tamemoto, H., Kadowaki, T., Tobe, K., Yagi, T., Sakura, H., Hayakawa, T., Terauchi, Y., Ueki, K., Kaburagi, Y., Satoh, S., et al. (1994). Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372, 182-186.
29. Tozzo, E., Gnudi, L., and Kahn, B.B. (1997). Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter. Endocrinology 138, 1604-1611.
30. Trask, R.V., and Billadello, J.J. (1990). Tissue-specific distribution and developmental regulation of M and B creatine kinase mRNAs. Biochim. Biophys. Acta 1049, 182-188.
31. Tsao, T.S., Stenbit, A.E., Li, J., Houseknecht, K.L., Zierath, J.R., Katz, E.B., and Charron, M.J. (1997). Muscle-specific transgenic complementation of GLUT4-deficient mice. J. Clin. Invest. 100, 671-677.
32. Warram, J.H., Rich, S.S., and Krolewski, A.S. (1995). Epidemiology and genetics of diabetes mellitus. In Joslin's Diabetes Mellitus. C.R. Kahn and G.C. Weir, eds. (Philadelphia: Lea and Febiger).
33. Withers, D.J., Sanchez-Gutierrez, J.C., Towery, H., Ren, J.M., Burks, D.J., Previs, S., Zhang, Y., Bernal, D., Pons, S., Shulman, G.I., et al. (1998). Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391, 900-903.
34. Wurst, W., and Joyner, A.L. (1993). Production of targeted embryonic stem cell clones. In Gene Targeting: A Practical Approach, A.L. Joyner, ed. (New York: Oxford University Press), pp. 33-61.
35. Young, M.E., Radd, G.K., and Leighton, B. (1997). Nitric oxide stimulates glucose transport and metabolism in rat skeletal muscle in vitro. Biochem. J. 322, 223-228.